Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial

dc.contributor.authorGonzález Ortega, Itxaso
dc.contributor.authorEcheburúa, Enrique
dc.contributor.authorAlberich, Susana
dc.contributor.authorBernardo Arroyo, Miquel
dc.contributor.authorVieta i Pascual, Eduard, 1963-
dc.contributor.authorSalazar de Pablo, Gonzalo
dc.contributor.authorGonzález-Pinto, Ana
dc.date.accessioned2023-01-10T16:08:35Z
dc.date.available2023-01-10T16:08:35Z
dc.date.issued2022-06-15
dc.date.updated2023-01-10T16:08:35Z
dc.description.abstractDespite the negative influence of cannabis use on the development and prognosis of first-episode psychosis (FEP), there is little evidence on effective specific interventions for cannabis use cessation in FEP. The aim of this study was to compare the efficacy of a specific cognitive behavioral therapy (CBT) for cannabis cessation (CBT-CC) with treatment as usual (TAU) in FEP cannabis users. In this single-blind, 1-year randomized controlled trial, 65 participants were randomly assigned to CBT-CC or TAU. The primary outcome was the reduction in cannabis use severity. The CBT-CC group had a greater decrease in cannabis use severity and positive psychotic symptoms over time, and a greater improvement in functioning at post-treatment than TAU. The treatment response was also faster in the CBT-CC group, reducing cannabis use, anxiety, positive and general psychotic symptoms, and improving functioning earlier than TAU in the follow-up. Moreover, patients who stopped and/or reduced cannabis use during the follow-up, decreased psychotic symptoms and increased awareness of disease compared to those who continued using cannabis. Early intervention based on a specific CBT for cannabis cessation, may be effective in reducing cannabis use severity, in addition to improving clinical and functional outcomes of FEP cannabis users.
dc.format.extent19 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec724244
dc.identifier.idimarina9315987
dc.identifier.issn1661-7827
dc.identifier.pmid35742573
dc.identifier.urihttps://hdl.handle.net/2445/192062
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijerph19127325
dc.relation.ispartofInternational Journal of Environmental Research and Public Health, 2022, vol. 19, num. 12, p. 7325
dc.relation.urihttps://doi.org/10.3390/ijerph19127325
dc.rightscc-by (c) González Ortega, Itxaso et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationPsicosi
dc.subject.classificationCànnabis
dc.subject.classificationTeràpia cognitiva
dc.subject.classificationAvaluació de resultats (Assistència mèdica)
dc.subject.classificationAssaigs clínics
dc.subject.otherPsychoses
dc.subject.otherCannabis
dc.subject.otherCognitive therapy
dc.subject.otherOutcome assessment (Medical care)
dc.subject.otherClinical trials
dc.titleCognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
724244.pdf
Mida:
1.6 MB
Format:
Adobe Portable Document Format